A case of secretin-responsive insulinoma with low serum C-peptide levels

Endocrine Journal

Volumn 54, Issue 1, 2007, Pages 113-121

  Fujikura, Junji ^a   Hosoda, Kiminori ^a   Noguchi, Michio ^a   Ebihara, Ken ^a   Masuzaki, Hiroaki ^a   Hirata, Masakazu ^a   Fujimoto, Koji ^a   Doi, Ryuichiro ^a   Iwanishi, Masanori ^b   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Kusatsu General Hospital   (Japan)

Author keywords

C peptide; Cathepsin B; Insulinoma; Secretin

Indexed keywords

C PEPTIDE; CALCIUM; CATHEPSIN B; SECRETIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERINSULINEMIA; INSULINOMA; LABORATORY TEST; RADIODIAGNOSIS; SURGICAL TECHNIQUE;

BLOOD GLUCOSE; C-PEPTIDE; FEMALE; HUMANS; INSULIN; INSULINOMA; MIDDLE AGED; PANCREATIC NEOPLASMS; SECRETIN;

EID: 33947609990     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K06-148     Document Type: Article

References (36)

1. Service FJ, McMahon MM, O'Brien PC, Ballard DJ (1991) Functioning insulinoma - incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 66: 711-719.
2. Grunt JA, Pallotta JA, Soeldner JS (1970) Blood sugar, serum insulin and free fatty acid interrelationships during intravenous tolbutamide testing in normal young adults and in patients with insulinoma. Diabetes 19: 122-126.
3. Turner RC, Oakley NW, Nabarro JD (1971) Control of basal insulin secretion, with special reference to the diagnosis of insulinomas. Br Med J 2: 132-135.
4. Fajans SS, Floyd JC Jr (1976) Fasting hypoglycemia in adults. N Engl J Med 294: 766-772.
5. McAuley G, Delaney H, Colville J, Lyburn I, Worsley D, Govender P, Torreggiani WC (2005) Multimodality preoperative imaging of pancreatic insulinomas. Clin Radiol 60: 1039-1050.
6. Imamura M, Hattori Y, Nishida O, Honda T, Shimada Y, Miyahara T, Wagata T, Baba N, Tobe T (1990) Unresponsiveness of insulinoma cells to secretin: significance of the secretin test in patients with insulinoma. Pancreas 5: 467-473.
7. Imamura M, Shimada Y, Kato M, Doi R, Okada N, Hashimoto M (1994) Usefulness of selective arterial calcium injection test and secretin test in patients with insulinoma. J Hep Bil Pancr Surg 1: 530-534.
8. Tanaka N, Hosoi M, Yamamoto T, Yoshioka K, Ishii T, Sato T, Tanaka S, Yamazaki O, Manabe T, Toyokawa A, Fujii S (2002) An insulinoma for which secretin test and selective arterial calcium injection test were useful. Intern Med 41: 839-841.
9. Steiner DF, Cunningham D, Spigelman L, Aten B (1967) Insulin biosynthesis: evidence for a precursor. Science 157: 697-700.
10. Bonser AM, Garcia-Webb P (1984) C-peptide measurement: methods and clinical utility. Crit Rev Clin Lab Sci 19: 297-352.
11. Service FJ, O'Brien PC, Kao PC, Young WF Jr (1992) C-peptide suppression test: effects of gender, age, and body mass index; implications for the diagnosis of insulinoma. J Clin Endocrinol Metab 74: 204-210.
12. Service FJ, O'Brien PC, McMahon MM, Kao PC (1993) C-peptide during the prolonged fast in insulinoma. J Clin Endocrinol Metab 76: 655-659.
13. Chammas NK, Teale JD, Quin JD (2003) Insulinoma: how reliable is the biochemical evidence? Ann Clin Biochem 40: 689-693.
14. Doppman JL, Miller DL, Chang R, Shawker TH, Gorden P, Norton JA (1991) Insulinomas: localization with selective intraarterial injection of calcium. Radiology 178: 237-241.
15. Conlon JM, Hoog A, Grimelius L (1995) Intracellular degradation of the C-peptide of proinsulin, in a human insulinoma: identification of sites of cleavage and evidence for a role for cathepsin B. Pancreas 10: 167-172.
16. O'Hare MM, Shaw C, Swanston-Flatt SK, Marcelli M, Buchanan KD, Flatt PR (1985) Influence of a transplantable insulinoma on the pancreatic status of insulin and pancreatic polypeptide in the rat. Diabetologia 28: 157-160.
17. Glaser B, Shapiro B, Glowniak J, Fajans SS, Vinik AI (1988) Effects of secretin on the normal and pathological beta-cell. J Clin Endocrinol Metab 66: 1138-1143.
18. Sakai T, Ohneda A, Nihei J, Kobayashi T (1982) Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man. Tohoku J Exp Med 138: 427-440.
19. Kajinuma H, Kanazawa Y, Sando H, Hayashi M, Kawazu S, Kosaka K (1979) Human plasma C-peptide immunoreactivity: Its correlation with immunoreactive insulin in diabetes, and chronic liver and renal diseases. Endocrinol Jpn 26: 65-73.
20. Okada N, Kobayashi M, Ohtsuka H, Shigematsu S, Nagasawa Y, Komatsu M, Aizawa T, Yamada T (1992) Differential effects of body weight, hyperinsulinemia and oral glucose load on serum C-peptide/insulin molar ratio. Horm Metab Res 24: 429-433.
21. Smythe AR 2nd, McFarland KF, Yousufuddin M, Meredith WD (1990) Multiple endocrine adenomatosis type I in pregnancy. Am J Obstet Gynecol 163: 1037-1039.
22. Katabami T, Kato H, Shirai N, Naito S, Saito N (2005) Successful long-term treatment with once-daily injection of low-dose octreotide in an aged patient with insulinoma. Endocr J 52: 629-634.
23. Gin H, Brottier E, Dupuy B, Guillaume D, Ponzo J, Aubertin J (1987) Use of the glucose clamp technique for confirmation of insulinoma autonomous hyperinsulinism. Arch Intern Med 147: 985-987.
24. Scarlett JA, Mako ME, Rubenstein AH, Blix PM, Goldman J, Horwitz DL, Tager H, Jaspan JB, Stjernholm MR, Olefsky JM (1977) Factitious hypoglycemia. Diagnosis by measurement of serum C-peptide immunoreactivity and insulin-binding antibodies. N Engl J Med 297: 1029-1032.
25. Saudek CD (1990) Recurrent hypoglycemia. JAMA 264: 2791-2794.
26. Gerbitz KD, Spelsberg F (1985) Pancreatic B-cell peptides as parameters for diagnosis and localisation of hormone secreting tumours. J Clin Chem Clin Biochem 23: 377-380.
27. Lebowitz MR, Blumenthal SA (1993) The molar ratio of insulin to C-peptide. An aid to the diagnosis of hypoglycemia due to surreptitious (or inadvertent) insulin administration. Arch Intern Med 153: 650-655.
28. Kondo T, Tomita S, Adachi H, Motoshima H, Taketa K, Matsuyoshi A, Tokunaga H, Miyamura N, Araki E (2005) A case of hyperinsulinemia of undetermined origin, successfully treated with long-acting octreotide. Endocr J 52: 511-517.
29. Service FJ (1983) Clinical presentation and laboratory evaluation of hypoglycemic disorders in adults. In: Service FJ, Hypoglycemic Disorders: Pathogenesis, Diagnosis, and Treatment. GK Hall Medical Publishers, Boston, Mass: 82.
30. Ciavarella A, Vannini P, Capelli M, De Battisti I, Mattioli L, Campione O, Bentini C, Greco V, Liguori L, Marrano D (1985) The artificial endocrine pancreas in the surgical treatment of insulinoma. Usefulness and limits. Ital J Surg Sci 15: 133-137.
31. Turner RC, Heding LG (1977) Plasma proinsulin, C-peptide and insulin in diagnostic suppression tests for insulinomas. Diabetologia 13: 571-577.
32. Ohneda A, Sakai T, Kobayashi T, Nihei J (1983) Insulin and C-peptide in plasma and tumor of insulinoma patients. Tohoku J Exp Med 139: 73-81.
33. Neerman-Arbez M, Halban PA (1993) Novel, noncrinophagic, degradation of connecting peptide in transformed pancreatic beta cells. J Biol Chem 268: 16248-16252.
34. Barrett AJ, Kirschke H (1981) Cathepsin B, Cathepsin H, and cathepsin L. Methods Enzymol 80: 535-561.
35. Sloane BF, Yan S, Podgorski I, Linebaugh BE, Cher ML, Mai J, Cavallo-Medved D, Sameni M, Dosescu J, Moin K (2005) Cathepsin B and tumor proteolysis: contribution of the tumor microenvironment. Semin Cancer Biol 15: 149-157.
36. Im B, Kominami E, Grube D, Uchiyama Y (1989) Immunocytochemical localization of cathepsins B and H in human pancreatic endocrine cells and insulinoma cells. Histochemistry 93: 111-118.